首页 > 最新文献

Laeknabladid最新文献

英文 中文
[Visual field loss in eyes undergoing minimally invasive glaucoma surgery in Iceland]. 【冰岛微创青光眼手术患者视野丧失】。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-12-01 DOI: 10.17992/lbl.2022.12.720
David Thor Jonsson, Olof Birna Olafsdottir, Maria Soffia Gottfredsdottir

Introduction: Glaucoma is a degenerative disease of the optic nerve and is marked by visual field defects (VFD). The only approved treatment is IOP lowering, either with eye drops, laser or surgery. Minimally invasive glaucoma surgery (MIGS) has become an appealing treatment modality, offering IOP lowering effect without the complication rates of trabeculectomy or the patient adherence required for pharmacologic therapy. In this study we aim to describe the severity of VFD in patients undergoing their first MIGS surgery.

Methods: Retrospective study reviewing the medical records of all patients that underwent MIGS surgery at the University Hospital of Iceland from January 2019 to June 2020. Eyes with previous glaucoma surgeries and secondary glaucomas were excluded. The results were divided into two groups, MIGS with phacoemulsification and standalone MIGS.

Results: 112 eyes included in the study. Mean age 74.5 ± 10.6 years. The mean defect (MD) score was 8.8 ± 6.4 and the number of glaucoma medications 1.8 ± 1.0 for the group as a whole. Significant difference (p<0.01) was between the age, MD score and the number of glaucoma medications between the two groups. Looking at the eyes that did not undergo phacoemulsification a significant difference (p<0.05) was between the MD score of primary open angle glaucoma eyes, 11.2 ± 6.5 dB and pseudoexfoliation glaucoma, 6.0 ± 3.3 dB.

Conclusion: Visual field defect and the number of glaucoma medications at referral to surgery was markedly less compared to a trabeculectomy study done in Iceland 3 years prior. Few comparable studies include MD score in their results, most focus on changes in intraocular pressure. Comparing the MD score to three studies from Germany and Austria the MD score seems to be similar. In our study a lower MD score for pseudoexfoliation glaucoma implies that Icelandic ophthalmologists send pseudoexfoliation eyes earlier for an operation.

青光眼是一种视神经退行性疾病,以视野缺损(VFD)为特征。唯一被批准的治疗方法是降低眼压,用滴眼液、激光或手术都行。微创青光眼手术(MIGS)已经成为一种很有吸引力的治疗方式,它既没有小梁切除术的并发症,也没有药物治疗所需的患者依从性,可以提供降低IOP的效果。在这项研究中,我们的目的是描述VFD的严重程度在患者接受他们的第一次MIGS手术。方法:回顾性研究,回顾2019年1月至2020年6月在冰岛大学医院接受MIGS手术的所有患者的病历。既往青光眼手术及继发性青光眼排除在外。结果分为两组,米格斯联合超声乳化和独立米格斯。结果:112只眼纳入研究。平均年龄74.5±10.6岁。平均缺损(MD)评分为8.8±6.4分,青光眼用药次数为1.8±1.0次。结论:与3年前在冰岛进行的一项小梁切除术研究相比,视野缺损和青光眼药物转诊手术的数量明显减少。很少有可比较的研究将MD评分纳入其结果,大多数研究关注的是眼压的变化。将MD分数与德国和奥地利的三项研究进行比较,MD分数似乎是相似的。在我们的研究中,假性脱落性青光眼的MD评分较低,这意味着冰岛眼科医生更早地将假性脱落的眼睛送去手术。
{"title":"[Visual field loss in eyes undergoing minimally invasive glaucoma surgery in Iceland].","authors":"David Thor Jonsson,&nbsp;Olof Birna Olafsdottir,&nbsp;Maria Soffia Gottfredsdottir","doi":"10.17992/lbl.2022.12.720","DOIUrl":"https://doi.org/10.17992/lbl.2022.12.720","url":null,"abstract":"<p><strong>Introduction: </strong>Glaucoma is a degenerative disease of the optic nerve and is marked by visual field defects (VFD). The only approved treatment is IOP lowering, either with eye drops, laser or surgery. Minimally invasive glaucoma surgery (MIGS) has become an appealing treatment modality, offering IOP lowering effect without the complication rates of trabeculectomy or the patient adherence required for pharmacologic therapy. In this study we aim to describe the severity of VFD in patients undergoing their first MIGS surgery.</p><p><strong>Methods: </strong>Retrospective study reviewing the medical records of all patients that underwent MIGS surgery at the University Hospital of Iceland from January 2019 to June 2020. Eyes with previous glaucoma surgeries and secondary glaucomas were excluded. The results were divided into two groups, MIGS with phacoemulsification and standalone MIGS.</p><p><strong>Results: </strong>112 eyes included in the study. Mean age 74.5 ± 10.6 years. The mean defect (MD) score was 8.8 ± 6.4 and the number of glaucoma medications 1.8 ± 1.0 for the group as a whole. Significant difference (p<0.01) was between the age, MD score and the number of glaucoma medications between the two groups. Looking at the eyes that did not undergo phacoemulsification a significant difference (p<0.05) was between the MD score of primary open angle glaucoma eyes, 11.2 ± 6.5 dB and pseudoexfoliation glaucoma, 6.0 ± 3.3 dB.</p><p><strong>Conclusion: </strong>Visual field defect and the number of glaucoma medications at referral to surgery was markedly less compared to a trabeculectomy study done in Iceland 3 years prior. Few comparable studies include MD score in their results, most focus on changes in intraocular pressure. Comparing the MD score to three studies from Germany and Austria the MD score seems to be similar. In our study a lower MD score for pseudoexfoliation glaucoma implies that Icelandic ophthalmologists send pseudoexfoliation eyes earlier for an operation.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40547132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Fire-works related eye injuries]. [与火灾有关的眼部伤害]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-12-01 DOI: 10.17992/lbl.2022.12.718
Gunnar Mar Zoega
{"title":"[Fire-works related eye injuries].","authors":"Gunnar Mar Zoega","doi":"10.17992/lbl.2022.12.718","DOIUrl":"https://doi.org/10.17992/lbl.2022.12.718","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10718880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Did ketogenic diet in past centuries protect against the consequence of the cystatin L68Q mutation in carriers of HCCAA?] 过去几个世纪的生酮饮食是否可以防止HCCAA携带者胱抑素L68Q突变的后果?]
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-12-01 DOI: 10.17992/lbl.2022.12.721
Astridur Palsdottir, Asbjorg Osk Snorradottir, Hakon Hakonarson

Hereditary cystatin C amyloid angiopathy (HCCAA) is a dominantly inherited disease caused by a mutation (L68Q) in the cystatin C gene, CST3. Mutant cystatin C protein accumulates as amyloid in arterioles in the brain leading to repeated brain hemorrhages and death of young carriers. Recently a possible treatment option was reported for HCCAA carriers involving an oral treatment with N-acetyl-cysteine in order to increase glutathione which was found to dissolve aggregates of mutant cystatin C. An earlier study described how the life span of carriers of the L68Q mutation shortened in the latter half of the 19th century. During the same decades a drastic change occured in the diet in Iceland. In the beginning of the century the diet was simple and low in carbohydrates, which mostly came from milk products. Import of grains and sugar was limited, but increased greatly according to import records. Due to lack of salt, food was preserved in acid whey, but gradually salt replaced whey as means of preserving food. This study aims to explore if changes in the diet of Icelanders during the same decades could possibly affect the amount of glutathione in people.

遗传性胱抑素C淀粉样血管病(HCCAA)是一种由胱抑素C基因CST3突变(L68Q)引起的显性遗传性疾病。突变的胱氨酸抑制素C蛋白以淀粉样蛋白的形式在大脑的小动脉中积累,导致年轻携带者反复出现脑出血和死亡。最近报道了一种可能的HCCAA携带者的治疗选择,包括口服n -乙酰半胱氨酸治疗,以增加谷胱甘肽,发现谷胱甘肽可以溶解突变型胱抑素c的聚集体。一项早期的研究描述了19世纪下半叶L68Q突变携带者的寿命如何缩短。在同样的几十年里,冰岛的饮食发生了巨大的变化。在本世纪初,饮食很简单,碳水化合物含量低,主要来自奶制品。粮食和糖的进口是有限的,但根据进口记录,大大增加了。由于缺乏盐,食物被保存在酸性乳清中,但盐逐渐取代乳清作为保存食物的手段。这项研究的目的是探索冰岛人在同一时期的饮食变化是否可能影响人们体内谷胱甘肽的含量。
{"title":"[Did ketogenic diet in past centuries protect against the consequence of the cystatin L68Q mutation in carriers of HCCAA?]","authors":"Astridur Palsdottir,&nbsp;Asbjorg Osk Snorradottir,&nbsp;Hakon Hakonarson","doi":"10.17992/lbl.2022.12.721","DOIUrl":"https://doi.org/10.17992/lbl.2022.12.721","url":null,"abstract":"<p><p>Hereditary cystatin C amyloid angiopathy (HCCAA) is a dominantly inherited disease caused by a mutation (L68Q) in the cystatin C gene, CST3. Mutant cystatin C protein accumulates as amyloid in arterioles in the brain leading to repeated brain hemorrhages and death of young carriers. Recently a possible treatment option was reported for HCCAA carriers involving an oral treatment with N-acetyl-cysteine in order to increase glutathione which was found to dissolve aggregates of mutant cystatin C. An earlier study described how the life span of carriers of the L68Q mutation shortened in the latter half of the 19th century. During the same decades a drastic change occured in the diet in Iceland. In the beginning of the century the diet was simple and low in carbohydrates, which mostly came from milk products. Import of grains and sugar was limited, but increased greatly according to import records. Due to lack of salt, food was preserved in acid whey, but gradually salt replaced whey as means of preserving food. This study aims to explore if changes in the diet of Icelanders during the same decades could possibly affect the amount of glutathione in people.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40556478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evidence-based practice rather than the traditional approach]. [循证实践而不是传统方法]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-12-01 DOI: 10.17992/lbl.2022.12.717
Gudrun Thuridur Hoskuldsdottir
{"title":"[Evidence-based practice rather than the traditional approach].","authors":"Gudrun Thuridur Hoskuldsdottir","doi":"10.17992/lbl.2022.12.717","DOIUrl":"https://doi.org/10.17992/lbl.2022.12.717","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10718879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Emergency Department visits due to firework accidents in the Reykjavik capital area from 2010 to 2022]. [2010年至2022年雷克雅未克首都地区因烟花事故而进行的急诊访问]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-12-01 DOI: 10.17992/lbl.2022.12.719
Bjorn Vilhelm Olafsson, Hjalti Mar Bjornsson

Background: Public use of fireworks is widespread in Iceland, and unfortunately associated with injuries. No prior comprehensive research has been done on firework accidents in Iceland. The goal of this study was to gather information about the extent, cause, and impact of firework accidents in the Reykjavik capital area.

Methods: Text search was conducted in medical records to find visits to the Emergency Department (ED) resulting from fireworks accidents over the period December 2010 to January 2022. Medical records were reviewed for details of events and injury.

Results: Over the period 248 patients came to the ED after a firework related injury, 73% male. The age range was from 9 months to 79 years of age. Children were 114, 12 were younger than 6 years. There where overall 54 secondary accidents. In total 96 (39%) accidents were traced to a faulty firework. Rockets caused the most accidents 56 (23%), cakes 43 (17%) and handheld candles 32 (13%). Type of firework was not reported in 62 (25%) cases. 157 sustained a burn injury, of which 104 where on hands. Eye injury was found on 67 patients and 97 individuals had open wounds. 22 where admitted to the hospital for a total of 91 days. Nobody died but at least 13 sustained permanent physical impairment due to fireworks.

Conclusions: Over the past decade, 21 patients on average presented to the ED annually with firework injury. 73% of those injured by fireworks are male. Children make up one half of the injured and one child 5 years of age or younger sustains a firework injury every year on average. Preventive measures against firework accidents should be expanded and more restrictive regulations on their use should be considered.

背景:在冰岛,公共场所燃放烟花很普遍,不幸的是,这与伤害有关。此前没有对冰岛的烟花事故进行过全面的研究。本研究的目的是收集有关雷克雅未克首都地区烟花事故的程度、原因和影响的信息。方法:对2010年12月至2022年1月期间因烟花事故到急诊室就诊的医疗记录进行文本检索。审查了医疗记录,以了解事件和受伤的细节。结果:在此期间,248名患者在烟花相关损伤后来到急诊科,其中73%为男性。年龄范围为9个月~ 79岁。114名儿童中有12名小于6岁。总共有54起次要事故。总共有96起(39%)事故被追溯到有缺陷的烟花。火箭造成的事故最多,为56起(23%),蛋糕43起(17%),手持蜡烛32起(13%)。62例(25%)未见烟花类型。157人烧伤,其中104人手部受伤。67例患者眼部受伤,97例患者有开放性伤口。其中22人住院共91天。没有人死亡,但至少13人因烟花造成永久性身体损伤。结论:在过去的十年中,平均每年有21例患者因烟花损伤来到急诊科。73%的烟花伤者是男性。儿童占受伤者的一半,平均每年有一名5岁或5岁以下的儿童遭受烟花伤害。应扩大对烟花事故的预防措施,并应考虑对其使用制定更严格的规定。
{"title":"[Emergency Department visits due to firework accidents in the Reykjavik capital area from 2010 to 2022].","authors":"Bjorn Vilhelm Olafsson,&nbsp;Hjalti Mar Bjornsson","doi":"10.17992/lbl.2022.12.719","DOIUrl":"https://doi.org/10.17992/lbl.2022.12.719","url":null,"abstract":"<p><strong>Background: </strong>Public use of fireworks is widespread in Iceland, and unfortunately associated with injuries. No prior comprehensive research has been done on firework accidents in Iceland. The goal of this study was to gather information about the extent, cause, and impact of firework accidents in the Reykjavik capital area.</p><p><strong>Methods: </strong>Text search was conducted in medical records to find visits to the Emergency Department (ED) resulting from fireworks accidents over the period December 2010 to January 2022. Medical records were reviewed for details of events and injury.</p><p><strong>Results: </strong>Over the period 248 patients came to the ED after a firework related injury, 73% male. The age range was from 9 months to 79 years of age. Children were 114, 12 were younger than 6 years. There where overall 54 secondary accidents. In total 96 (39%) accidents were traced to a faulty firework. Rockets caused the most accidents 56 (23%), cakes 43 (17%) and handheld candles 32 (13%). Type of firework was not reported in 62 (25%) cases. 157 sustained a burn injury, of which 104 where on hands. Eye injury was found on 67 patients and 97 individuals had open wounds. 22 where admitted to the hospital for a total of 91 days. Nobody died but at least 13 sustained permanent physical impairment due to fireworks.</p><p><strong>Conclusions: </strong>Over the past decade, 21 patients on average presented to the ED annually with firework injury. 73% of those injured by fireworks are male. Children make up one half of the injured and one child 5 years of age or younger sustains a firework injury every year on average. Preventive measures against firework accidents should be expanded and more restrictive regulations on their use should be considered.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40457343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Dawn of a new Day - A brief History of Stroke Treatment in Iceland]. [新的一天的黎明-冰岛中风治疗简史]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-11-01 DOI: doi 10.17992/lbl.2022.11.716
Brynhildur Thors, Vilhjalmur Vilmarsson

Here we will briefly review the main influential factors and milestones in the history of stroke care in Iceland. Over the last few decades the treatment of ischemic stroke has revolutionized in many ways and so has the general mindset of those providing it. This review article is partly based upon interviews with Icelandic doctors that partook in the development. Looking back at this history it is clear that, in many ways, the medical care in Iceland was at the forefront in implementing those emerging new treatments in stroke care. This is mainly on account of ambitious and hard working individuals that were not easily dissuaded but firmly believed in the possibility of better outcomes for their stroke patients.

在这里,我们将简要回顾冰岛中风护理史上的主要影响因素和里程碑。在过去的几十年里,缺血性中风的治疗在许多方面都发生了革命性的变化,提供缺血性中风治疗的人的普遍心态也发生了变化。这篇评论文章部分基于对参与开发的冰岛医生的采访。回顾这段历史,很明显,在许多方面,冰岛的医疗保健在实施这些新兴的中风治疗方法方面走在了前列。这主要是由于那些雄心勃勃、努力工作的人不容易被劝阻,而是坚信他们的中风患者可能会有更好的结果。
{"title":"[Dawn of a new Day - A brief History of Stroke Treatment in Iceland].","authors":"Brynhildur Thors,&nbsp;Vilhjalmur Vilmarsson","doi":"doi 10.17992/lbl.2022.11.716","DOIUrl":"https://doi.org/doi 10.17992/lbl.2022.11.716","url":null,"abstract":"<p><p>Here we will briefly review the main influential factors and milestones in the history of stroke care in Iceland. Over the last few decades the treatment of ischemic stroke has revolutionized in many ways and so has the general mindset of those providing it. This review article is partly based upon interviews with Icelandic doctors that partook in the development. Looking back at this history it is clear that, in many ways, the medical care in Iceland was at the forefront in implementing those emerging new treatments in stroke care. This is mainly on account of ambitious and hard working individuals that were not easily dissuaded but firmly believed in the possibility of better outcomes for their stroke patients.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40676285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cardiac transplantation and donation in Icelandic patients - indications and outcome]. [冰岛患者的心脏移植和捐赠-适应症和结果]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-11-01 DOI: 10.17992/lbl.2022.11.714
A. Valgardsson, T. Hrafnkelsdóttir, Tomas Thor Kristjansson, Hildigunnur Fridjonsdottir, K. Sigvaldason, G. Dellgren, T. Gudbjartsson
INTRODUCTIONInformation on the number, indications and outcome of cardiac transplantations in Icelandic patients is scarce, as is information on the number of hearts donated from Iceland for cardiac transplantation.MATERIAL AND METHODSA retrospective study on patients receiving heart transplantation from the first procedure in 1988 until March 2019. Clinical information was gathered from Landspitali Transplantation Clinic, patient charts, and information on donated hearts from the Icelandic Donation Registry. Age-standardized incidence of the procedure was calculated, and overall survival (Kaplan-Meier) estimated. Mean follow-up was 10.3 years.RESULTSAltogether 24 patients (19 males, median age 38 years, range: 4-65 years) underwent cardiac transplantation; that included one re-transplantation, three simultaneous heart- and lung transplants and two heart- and kidney transplants. The transplantations were performed in Gothenburg (n=20), London (n=3) and Copenhagen (n=2). Most common indications were dilated cardiomyopathy (n=10), congenital heart disease (n=4), and viral myocarditis (n=3). Five patients were bridged left ventricular-assist device preoperatively. Overall survival at 1 and 5 years was 91% and 86%, respectively; median survival being 24 years. The incidence of cardiac transplantation was 2.7 heart-TX pmp/year but increased to 4.6 heart-TX pmp/year after 2008 (p=0.01). During the same period 42 hearts were donated from Iceland for transplantation abroad, the first in 2002 and increasing from 0.8 to 3.0 hearts/year during the first and second half of the study-period, respectively.CONCLUSIONSurvival of Icelandic cardiac transplant recipients is good and comparable to larger transplant centers overseas. Number of hearts donated from Iceland have increased and currently Iceland donates twice as many hearts at it receives.
关于冰岛患者心脏移植的数量、适应症和结果的信息很少,关于冰岛捐赠用于心脏移植的心脏数量的信息也很少。材料与方法对1988年至2019年3月接受心脏移植的患者进行回顾性研究。临床信息收集自Landspitali移植诊所,患者图表,以及来自冰岛捐赠登记处的捐赠心脏信息。计算手术的年龄标准化发生率,并估计总生存率(Kaplan-Meier)。平均随访时间为10.3年。结果24例患者(男性19例,中位年龄38岁,范围4 ~ 65岁)行心脏移植手术;其中包括一次再移植,三次同时进行的心脏和肺移植以及两次心脏和肾脏移植。移植分别在哥德堡(n=20)、伦敦(n=3)和哥本哈根(n=2)进行。最常见的适应症是扩张型心肌病(n=10)、先天性心脏病(n=4)和病毒性心肌炎(n=3)。5例患者术前采用左心室辅助装置桥接。1年和5年的总生存率分别为91%和86%;中位生存期为24年。心脏移植发生率为2.7心脏- tx pmp/年,2008年后增加到4.6心脏- tx pmp/年(p=0.01)。在同一时期,冰岛捐赠了42颗心脏用于国外移植,第一次是在2002年,在研究期间的上半年和下半年分别从0.8颗增加到3.0颗/年。结论冰岛心脏移植受者的生存率较好,可与国外较大的心脏移植中心相媲美。冰岛捐赠的心脏数量有所增加,目前冰岛捐赠的心脏数量是其接收的两倍。
{"title":"[Cardiac transplantation and donation in Icelandic patients - indications and outcome].","authors":"A. Valgardsson, T. Hrafnkelsdóttir, Tomas Thor Kristjansson, Hildigunnur Fridjonsdottir, K. Sigvaldason, G. Dellgren, T. Gudbjartsson","doi":"10.17992/lbl.2022.11.714","DOIUrl":"https://doi.org/10.17992/lbl.2022.11.714","url":null,"abstract":"INTRODUCTION\u0000Information on the number, indications and outcome of cardiac transplantations in Icelandic patients is scarce, as is information on the number of hearts donated from Iceland for cardiac transplantation.\u0000\u0000\u0000MATERIAL AND METHODS\u0000A retrospective study on patients receiving heart transplantation from the first procedure in 1988 until March 2019. Clinical information was gathered from Landspitali Transplantation Clinic, patient charts, and information on donated hearts from the Icelandic Donation Registry. Age-standardized incidence of the procedure was calculated, and overall survival (Kaplan-Meier) estimated. Mean follow-up was 10.3 years.\u0000\u0000\u0000RESULTS\u0000Altogether 24 patients (19 males, median age 38 years, range: 4-65 years) underwent cardiac transplantation; that included one re-transplantation, three simultaneous heart- and lung transplants and two heart- and kidney transplants. The transplantations were performed in Gothenburg (n=20), London (n=3) and Copenhagen (n=2). Most common indications were dilated cardiomyopathy (n=10), congenital heart disease (n=4), and viral myocarditis (n=3). Five patients were bridged left ventricular-assist device preoperatively. Overall survival at 1 and 5 years was 91% and 86%, respectively; median survival being 24 years. The incidence of cardiac transplantation was 2.7 heart-TX pmp/year but increased to 4.6 heart-TX pmp/year after 2008 (p=0.01). During the same period 42 hearts were donated from Iceland for transplantation abroad, the first in 2002 and increasing from 0.8 to 3.0 hearts/year during the first and second half of the study-period, respectively.\u0000\u0000\u0000CONCLUSION\u0000Survival of Icelandic cardiac transplant recipients is good and comparable to larger transplant centers overseas. Number of hearts donated from Iceland have increased and currently Iceland donates twice as many hearts at it receives.","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83015773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cardiac transplantation and donation in Icelandic patients - indications and outcome]. [冰岛患者的心脏移植和捐赠-适应症和结果]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-11-01 DOI: doi 10.17992/lbl.2022.11.714
Atli Steinn Valgardsson, Thordis Jona Hrafnkelsdottir, Tomas Thor Kristjansson, Hildigunnur Fridjonsdottir, Kristinn Sigvaldason, Goran Dellgren, Tomas Gudbjartsson

Introduction: Information on the number, indications and outcome of cardiac transplantations in Icelandic patients is scarce, as is information on the number of hearts donated from Iceland for cardiac transplantation.

Material and methods: A retrospective study on patients receiving heart transplantation from the first procedure in 1988 until March 2019. Clinical information was gathered from Landspitali Transplantation Clinic, patient charts, and information on donated hearts from the Icelandic Donation Registry. Age-standardized incidence of the procedure was calculated, and overall survival (Kaplan-Meier) estimated. Mean follow-up was 10.3 years.

Results: Altogether 24 patients (19 males, median age 38 years, range: 4-65 years) underwent cardiac transplantation; that included one re-transplantation, three simultaneous heart- and lung transplants and two heart- and kidney transplants. The transplantations were performed in Gothenburg (n=20), London (n=3) and Copenhagen (n=2). Most common indications were dilated cardiomyopathy (n=10), congenital heart disease (n=4), and viral myocarditis (n=3). Five patients were bridged left ventricular-assist device preoperatively. Overall survival at 1 and 5 years was 91% and 86%, respectively; median survival being 24 years. The incidence of cardiac transplantation was 2.7 heart-TX pmp/year but increased to 4.6 heart-TX pmp/year after 2008 (p=0.01). During the same period 42 hearts were donated from Iceland for transplantation abroad, the first in 2002 and increasing from 0.8 to 3.0 hearts/year during the first and second half of the study-period, respectively.

Conclusion: Survival of Icelandic cardiac transplant recipients is good and comparable to larger transplant centers overseas. Number of hearts donated from Iceland have increased and currently Iceland donates twice as many hearts at it receives.

导言:关于冰岛患者心脏移植的数量、适应症和结果的信息很少,关于冰岛捐赠用于心脏移植的心脏数量的信息也很少。材料与方法:对1988年至2019年3月接受心脏移植的患者进行回顾性研究。临床信息收集自Landspitali移植诊所,患者图表,以及来自冰岛捐赠登记处的捐赠心脏信息。计算手术的年龄标准化发生率,并估计总生存率(Kaplan-Meier)。平均随访时间为10.3年。结果:24例患者(男性19例,中位年龄38岁,范围4 ~ 65岁)行心脏移植手术;其中包括一次再移植,三次同时进行的心脏和肺移植以及两次心脏和肾脏移植。移植分别在哥德堡(n=20)、伦敦(n=3)和哥本哈根(n=2)进行。最常见的适应症是扩张型心肌病(n=10)、先天性心脏病(n=4)和病毒性心肌炎(n=3)。5例患者术前采用左心室辅助装置桥接。1年和5年的总生存率分别为91%和86%;中位生存期为24年。心脏移植发生率为2.7心脏- tx pmp/年,2008年后增加到4.6心脏- tx pmp/年(p=0.01)。在同一时期,冰岛捐赠了42颗心脏用于国外移植,第一次是在2002年,在研究期间的上半年和下半年分别从0.8颗增加到3.0颗/年。结论:冰岛心脏移植受者的生存率较好,可与国外较大的移植中心相媲美。冰岛捐赠的心脏数量有所增加,目前冰岛捐赠的心脏数量是其接收的两倍。
{"title":"[Cardiac transplantation and donation in Icelandic patients - indications and outcome].","authors":"Atli Steinn Valgardsson,&nbsp;Thordis Jona Hrafnkelsdottir,&nbsp;Tomas Thor Kristjansson,&nbsp;Hildigunnur Fridjonsdottir,&nbsp;Kristinn Sigvaldason,&nbsp;Goran Dellgren,&nbsp;Tomas Gudbjartsson","doi":"doi 10.17992/lbl.2022.11.714","DOIUrl":"https://doi.org/doi 10.17992/lbl.2022.11.714","url":null,"abstract":"<p><strong>Introduction: </strong>Information on the number, indications and outcome of cardiac transplantations in Icelandic patients is scarce, as is information on the number of hearts donated from Iceland for cardiac transplantation.</p><p><strong>Material and methods: </strong>A retrospective study on patients receiving heart transplantation from the first procedure in 1988 until March 2019. Clinical information was gathered from Landspitali Transplantation Clinic, patient charts, and information on donated hearts from the Icelandic Donation Registry. Age-standardized incidence of the procedure was calculated, and overall survival (Kaplan-Meier) estimated. Mean follow-up was 10.3 years.</p><p><strong>Results: </strong>Altogether 24 patients (19 males, median age 38 years, range: 4-65 years) underwent cardiac transplantation; that included one re-transplantation, three simultaneous heart- and lung transplants and two heart- and kidney transplants. The transplantations were performed in Gothenburg (n=20), London (n=3) and Copenhagen (n=2). Most common indications were dilated cardiomyopathy (n=10), congenital heart disease (n=4), and viral myocarditis (n=3). Five patients were bridged left ventricular-assist device preoperatively. Overall survival at 1 and 5 years was 91% and 86%, respectively; median survival being 24 years. The incidence of cardiac transplantation was 2.7 heart-TX pmp/year but increased to 4.6 heart-TX pmp/year after 2008 (p=0.01). During the same period 42 hearts were donated from Iceland for transplantation abroad, the first in 2002 and increasing from 0.8 to 3.0 hearts/year during the first and second half of the study-period, respectively.</p><p><strong>Conclusion: </strong>Survival of Icelandic cardiac transplant recipients is good and comparable to larger transplant centers overseas. Number of hearts donated from Iceland have increased and currently Iceland donates twice as many hearts at it receives.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40676283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Screenings in Iceland: value, benefits and harm]. [在冰岛放映电影:价值、益处和危害]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-11-01 DOI: 10.17992/lbl.2022.11.712
Kristín Helga Birgisdóttir
{"title":"[Screenings in Iceland: value, benefits and harm].","authors":"Kristín Helga Birgisdóttir","doi":"10.17992/lbl.2022.11.712","DOIUrl":"https://doi.org/10.17992/lbl.2022.11.712","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89992594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Screenings in Iceland: value, benefits and harm]. [在冰岛放映电影:价值、益处和危害]。
IF 0.4 4区 医学 Q4 Medicine Pub Date : 2022-11-01
Kristin Helga Birgisdottir
{"title":"[Screenings in Iceland: value, benefits and harm].","authors":"Kristin Helga Birgisdottir","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40676281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Laeknabladid
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1